Aaron Paul Kithcart: Connecting Science and Collaboration in Nagasaki
Aaron Paul Kithcart, Senior Medical Director in Translational and Clinical Sciences of Hematology at Regeneron, shared a post on LinkedIn:
“This weekend, I was in Nagasaki for the Japan College of Cardiology meeting.
It was a productive trip and a great opportunity to connect in person with investigators and colleagues participating in our FXI studies in atrial fibrillation and peripheral artery disease.
Beyond the scientific discussions, I really enjoyed learning more about Nagasaki and its unique place in Japanese history.
For centuries, Nagasaki served as Japan’s sole trading port open to foreign countries, making it an important gateway for international exchange and the exchange of ideas.
It was a great visit all around, and I’m grateful to all of the investigators and colleagues who took the time to meet, share their insights, and advance our work together.
Looking forward to many more years of collaboration and continuing the important work we are doing together in thrombosis.”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 02:59Caterina Casari: Curious about How Gene Editing is Revolutionizing Our Field?
-
Sep 15, 2026, 02:53Alejandro González Veliz: Can Lifestyle Changes Actually Reverse Atherosclerosis?
-
Sep 15, 2026, 02:08Eugenia Gianos: ACC CVPrevention Council’s New Statin Resources
-
Sep 15, 2026, 01:58Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A
-
Sep 15, 2026, 01:37Lesley Van Wyk: Exploring Sickle Cell Disease – The HbS Story
-
Sep 15, 2026, 01:31Luca Seffin: To the Science, the People, and the Journey – Thank You SR-Tiget
-
Sep 14, 2026, 23:49Heghine Khachatryan: New evidance – Antiphospholipid Antibodies and Ischemic Stroke
-
Sep 14, 2026, 23:42Eman M. Elsabbagh: Successful HCT Does Not End at Engraftment
-
Sep 14, 2026, 23:31Antonis Kattamis: Proud to Be Part of this Endeavour and Senior Author of the Pivotal Trial